ACM
CAPR icon

Aquatic Capital Management’s Capricor Therapeutics CAPR Stock Holding History

Aquatic Capital Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$632K Sell
26,257
-2,446
-9% -$74.2K 0.02% 715
2026
Q1 		$873K Buy
+28,703
New +$765K 0.03% 594
2025
Q3 		– Sell
-1
Closed -$10 – 1409
2025
Q2 		$10 Buy
+1
New +$11 ﹤0.01% 1209

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Aquatic Capital Management's CAPR Position: Q2 2026 in Review

Aquatic Capital Management reduced its Capricor Therapeutics (CAPR) stake by 8.5% in Q2 2026, selling an estimated $74.2K and leaving 26,257 shares worth $632K. The position accounts for 0.02% of the portfolio, ranked #715.

Aquatic Capital Management first reported a position in CAPR in Q2 2025 and has held it in 3 quarters since. The position peaked at $873K in Q1 2026. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Aquatic Capital Management held 26,257 shares of Capricor Therapeutics worth $632K as of Q2 2026.
  • Aquatic Capital Management sold 2,446 Capricor Therapeutics shares in Q2 2026, an estimated $74.2K.
  • Capricor Therapeutics made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #715 holding.
  • Aquatic Capital Management first reported a position in Capricor Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Aquatic Capital Management's Capricor Therapeutics position peaked at $873K in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.